On the semantics of clinical trials. The case of a 'pragmatic' trial in Alzheimer's disease.
In a recent original article [1] and the accompanying editorial [2], the term pragmatic was used to define a trial conducted to determine the efficacy of minocycline (daily doses of 400 mg or 200 mg) vs placebo in patients with mild Alzheimer's disease (MADE trial). Whereas the authors [1] mentioned 'pragmatic' only once, the editorialist mentioned it several times, and included it in the title [2].